Sana Biotechnology, Inc. SEC filings SANA
Sana Biotechnology, Inc. has 392 filings in SEC EDGAR's recent list, going back to Jun 26, 2020. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Sep 10, 2025 | — |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2025 | — |
| EFFECT | Filing | Mar 21, 2025 | — |
| POSASR | Filing | Mar 14, 2025 | — |
| EFFECT | Filing | May 1, 2023 | — |
| POS EX | Filing | May 1, 2023 | — |
| POSASR | Filing | Mar 15, 2023 | — |
| EFFECT | Filing | Feb 3, 2021 | — |
| CERT | Filing | Feb 3, 2021 | — |
| CORRESP | Letter to the SEC | Feb 1, 2021 | — |
| CORRESP | Letter to the SEC | Jan 28, 2021 | — |
| 8-A12B | Filing | Jan 25, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2021 | — |
| CORRESP | Letter to the SEC | Jan 20, 2021 | — |
| CORRESP | Letter to the SEC | Jan 12, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2021 | — |
| DRSLTR | Filing | Dec 18, 2020 | — |
| DRS/A | Filing | Dec 18, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 8, 2020 | — |
| DRS | Filing | Nov 10, 2020 | — |
| D | Filing | Jun 26, 2020 | — |
| D | Filing | Jun 26, 2020 | — |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SANA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Seattle, WA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1770121
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.